Delayed onset and decreased severity of experimental autoimmune uveoretinitis in mice lacking nitric oxide synthase type 2

Journal of Neuroimmunology

Volumn 110, Issue 1-2, 2000, Pages 31-44

  Thillaye Goldenberg, B ^a   Goureau, O ^a   Naud, M C ^a   De Kozak, Y ^a  

^a INSERM   (France)

Author keywords

Experimental autoimmune uveoretinitis; IL 10; Inflammation; Knock out mice; NO; Regulation

Indexed keywords

INTERLEUKIN 10; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE 2; RETINOID BINDING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME DEFICIENCY; ENZYME INDUCTION; ENZYME STRUCTURE; GENE DISRUPTION; HISTOPATHOLOGY; IMMUNOREGULATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; UVEORETINITIS;

ANIMAL; AUTOIMMUNE DISEASES; CELL DIVISION; CONCANAVALIN A; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IMMUNIZATION; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-10; LYMPHOCYTES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC-OXIDE SYNTHASE; RETINA; RETINITIS; RETINOL-BINDING PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; SPLEEN; SUPPORT, NON-U.S. GOV'T; TUMOR NECROSIS FACTOR; UVEITIS;

EID: 0034597129     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00313-1     Document Type: Article

References (43)

1. Barton K., McLaughlan M.T.M., Calder V.L., Lightman S. The kinetics of cytokine mRNA expression in the retina during experimental autoimmune uveoretinitis. Cell Immunol. 164:1995;133-140.
2. Behar-Cohen F., Parel J., Pouliquen Y., Thillaye-Goldenberg B., Goureau O., Heydolf S., et al. Iontophoresis of dexamethazone in the treatment of endotoxin-induced uveitis in rats. Exp. Eye Res. 65:1997;533-545.
3. Broekhuyse R., Huitinga E., Kuhlmann E., Van Rooijen N., Winkens H. Differential effects of macrophage depletion on two forms of experimental uveitis evoked by pigment epithelial membrane protein (EAPU), and by melanin-protein (EMIU). Exp. Eye Res. 65:1997;841-848.
4. Butler T.L., McMenamin P.G. Resident and infiltrating immune cells in the uveal tract in the early and late stages of experimental autoimmune uveoretinitis. Invest. Ophthalmol. Vis. Sci. 37:1996;2195-2210.
5. Caspi R., Chan C.C., Leake W., Higuchi M., Wiggert B., Chader G., et al. Experimental autoimmune uveoretinitis in mice. Induction by simple eliciting event and dependence on quantitative parameters of immunization. J. Autoimmun. 3:1990;237-246.
6. Caspi R.R., Chan C.C., Wiggert B., Chader G.J. The mouse as a model of experimental autoimmune uveoretinitis (EAU). Curr. Eye Res. 9:1990;169-173.
7. Caspi R., Roberge F., Chan C., Wiggert B., Chader G., Rosenszajn L., et al. A new model of autoimmune disease: experimental autoimmune uveoretinitis induced in mice by two different retinal antigens. J. Immunol. 140:1980;1480-1495.
8. Caspi R.R., Roberge F.G., McAllister C.C., El Saied M., Kuwabara T., Gery I., et al. T cell lines mediating experimental autoimmune uveoretinitis (EAU) in rat. J. Immunol. 136:1986;928-933.
9. Chan C., Caspi R., Ni M., Leake W., Wiggert B., Chader G., et al. Pathology of experimental autoimmune uveoretinitis in mice. J. Autoimmun. 3:1990;247-255.
10. Chomzynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
11. Cua D., Groux H., Hinton D., Stohlman S., Coffman R. Transgenic interleukin-10 prevents induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 189:1999;1005-1010.
12. de Kozak Y., Cotinet A., Goureau O., Hicks D., Thillaye-Goldenberg B. Tumor necrosis factor and nitric oxide production by resident retinal glial cells from rats presenting hereditary retinal degeneration. Ocul. Immunol. Inflamm. 5:1997;85-94.
13. de Kozak Y., Hicks D., Chatenoud L., Bellot J., Thillaye B., Faure J.P., et al. Intraocular TNF in endotoxin- and S-antigen-induced uveitis; in vitro synthesis of TNF by retinal Müller glial and pigment epithelial cells. Reg. Immunol. 6:1994;76-80.
14. Dighiero P., Reux I., Hauw J.J., Fillet A.M., Courtois Y., Goureau O., et al. Expression of inducible nitric oxide synthase in cytomegalovirus-infected glial cells of retinas from AIDS patients. Neurosci. Lett. 166:1994;31-34.
15. Forrester J.V., Liversidge J., Dua S., Towler H., McMenamin P.G. Comparison of clinical and experimental uveitis. Curr. Eye Res. 9:1990;75-84.
16. Goureau O., Hicks D., Courtois Y. Human retinal pigmented epithelial cells produce nitric oxide in response to cytokines. Biochem. Biophys. Res. Commun. 198:1994;120-126.
17. Goureau O., Hicks D., Courtois Y., de Kozak Y. Induction and regulation of nitric oxide synthase in retinal Müller glial cells. J. Neurochem. 63:1994;310-317.
18. Goureau O., Bellot J., Thillaye B., Courtois Y., de Kozak Y. Increased nitric oxide production in endotoxin-induced uveitis. J. Immunol. 154:1995;6518-6523.
19. Hayashi S., Guez-Crosier Y., Delvaux A., Velu T., Roberge F.G. Interleukin-10 inhibits inflammatory cells infiltration in endotoxin-induced uveitis. Graefe's Arch. Clin. Exp. Ophthalmol. 234:1996;633-636.
20. Hoey S., Grabowski P.S., Ralston S.H., Forrester J.V., Liversidge J. Nitric oxide accelerates the onset and increases the severity of experimental autoimmune uveoretinitis through an IFN-γ-dependent mechanism. J. Immunol. 159:1997;5132-5142.
21. Huitingha I., Van Rooijen N., de Groot C., Uitdehaag B., et al. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J. Exp. Med. 172:1990;1025-1029.
22. Jacquemin E., de Kozak Y., Thillaye B., Courtois Y., Goureau O. Expression of inducible nitric oxide synthase in the eye from endotoxin-induced uveitis rats. Invest. Ophthalmol. Vis. Sci. 37:1996;1187-1196.
23. Jones L., Rizzo L., Agarwal R., Tarrant T., Chan C., Wiggert B., et al. IFN-γ-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response. J. Immunol. 158:1997;5997-6005.
24. Knowles R.G., Moncada S. Nitric oxide synthase in mammals. Biochem. J. 298:1994;249-258.
25. Lyons C., Orloff G., Cunningham J. Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J. Biol. Chem. 207:1992;6370-6374.
26. MacMicking J., Xie Q.W., Nathan C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:1997;323-350.
27. MacMicking J.D., Nathan C., Hom G., Chartrain N., Fletcher D., Trumbauer M., et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 81:1994;641-650.
28. G-nitro L-arginine. Invest. Ophthalmol. Vis. Sci. 135:1994;3673-3680.
29. Marie O., Thillaye-Goldenberg B., Naud M., de Kozak Y. Interleukin-13 inhibits endotoxin-induced uveitis and potentiates local TNF-α and IL-6 production. Invest. Ophthalmol. Vis. Sci. 40:1999;2275-2282.
30. McMenamin P., Crewe J. Cellular localization and dynamics of nitric oxide synthase expression in the rat anterior segment during endotoxin-induced uveitis. Exp. Eye Res. 65:1997;157-164.
31. Mosman T. Properties and functions of interleukin-10. Adv. Immunol. 56:1994;1-26.
32. Nathan C. Inducible nitric oxide synthase: what difference does it makes? J. Clin. Invest. 100:1997;2417-2423.
33. Okada A., Sakai J., Usui M., Mizukichi J. Intraocular cytokine quantification of experimental autoimmune uveoretinitis in rats. Ocul. Immunol. Inflamm. 6:1998;111-120.
34. Parks D.J., Cheung M.K., Chan C.C., Roberge F.G. The role of nitric oxide in uveitis. Arch. Ophthalmol. 112:1994;544-546.
35. Pepperberg D., Okajima T., Ripps H., Chader G., Wiggert B. Functional properties of interphotoreceptor retinoid-binding protein. Photochem. Photobiol. 54:1991;1057-1060.
36. Pouvreau I., Zech J.C., Thillaye-Goldenberg B., Naud M.C., Van Rooijen N., de Kozak Y., et al. Effect of macrophage depletion by liposomes containing dichloromethylene diphosphonate on endotoxin-induced-uveitis. J. Neuroimmunol. 86:1998;171-181.
37. Rizzo L.V., Xu H., Chan C.C., Wiggert B., Caspi R.R. IL-10 has a protective role in experimental autoimmune uveoretinitis. Int. Immunol. 10:1998;807-814.
38. Rosenbaum J.T., Angell E. Paradoxical effects of IL-10 in endotoxin-induced uveitis. J. Immunol. 155:1995;4090-4094.
39. Rosenbaum J.T., MacDevitt H.O., Guss R.B., Egbert P.R. Endotoxin-induced uveitis in rats as a model for human disease. Nature. 286:1980;611-613.
40. Silver P., Tarrant T., Chan C., Wiggert B., Caspi R. Mice deficient in inducible nitric oxide synthase are susceptible to experimental autoimmune uveoretinitis. Invest. Ophthalmol. Vis. Sci. 40:1999;1280-1284.
41. Tilton R.G., Chang K., Corbett J.A., Misko T.P., Currie T.P., Bora N.S., et al. Endotoxin-induced uveitis in the rat is attenuated by inhibition of nitric oxide production. Invest. Ophthalmol. Vis. Sci. 35:1994;3278-3282.
42. Wei X., Charles I., Smith A., Ure J., Feng G., Huang F., et al. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature. 375:1995;408-411.
43. Wu G., Zhang J., Rao N. Peroxynitrite and oxidative damage in experimental autoimmune uveitis. Invest. Ophthalmol. Vis. Sci. 38:1997;1333-1339.